Home
About
Overview
Sharing Data
ORCID
Help
History (3)
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
Interlimb influences on paretic leg function in poststroke hemiparesis.
Neural substrate of sensitization to psychostimulants.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease. Neurotherapeutics. 2020 10; 17(4):1785-1795.
View in:
PubMed
subject areas
Antiparkinson Agents
Brain-Derived Neurotrophic Factor
Early Diagnosis
Female
Genetic Variation
Humans
Levodopa
Longitudinal Studies
Male
Parkinson Disease
Retrospective Studies
Treatment Outcome
authors with profiles
Jordan J. Elm